Arcutis Biotherapeutics Inc (ARQT)

Nov 04, 2025

Arcutis Biotherapeutics Achieves 186.45% Return, Establishing It as a Multibagger in Biotechnology - Markets Mojo

Nov 04, 2025

Nov 04, 2025

Arcutis Biotherapeutics (ARQT) Reports Positive Safety Data for ZORYVE Foam - GuruFocus

Nov 04, 2025

Nov 04, 2025

Arcutis Biotherapeutics Reports Long-Term Efficacy and Safety Data for ZORYVE® Foam 0.3% in Treating Seborrheic Dermatitis - Quiver Quantitative

Nov 04, 2025

Nov 04, 2025

Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data of ZORYVE® (roflumilast) Foam 0.3% in Individuals with Seborrheic Dermatitis in American Journal of Clinical Dermatology - The Manila Times

Nov 04, 2025

Nov 04, 2025

Arcutis (NASDAQ: ARQT) 52-week Phase 2 OLE: ZORYVE foam shows 80.4% clear/almost clear - Stock Titan

Nov 04, 2025

Nov 04, 2025

Corton Capital Inc. Acquires New Position in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat

Nov 04, 2025

Nov 04, 2025

How high can Arcutis Biotherapeutics Inc. stock goJobs Report & High Accuracy Swing Entry Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

Historical volatility pattern of Arcutis Biotherapeutics Inc. visualized2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com

Nov 04, 2025

Nov 04, 2025

What moving averages say about Arcutis Biotherapeutics Inc.July 2025 Retail & Free Reliable Trade Execution Plans - newser.com

Nov 04, 2025

Nov 04, 2025

Multi asset correlation models including Arcutis Biotherapeutics Inc.Market Trend Report & Weekly Top Stock Performers List - newser.com

Nov 04, 2025

Nov 04, 2025

How Arcutis Biotherapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com

Nov 04, 2025

Nov 04, 2025

What’s the recovery path for long term holders of Arcutis Biotherapeutics Inc.July 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com

Nov 04, 2025

Nov 03, 2025

Leading vs lagging indicators on Arcutis Biotherapeutics Inc. performanceShort Setup & Weekly Chart Analysis and Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Arcutis Biotherapeutics joins leaders at dermatology conference - Traders Union

Nov 03, 2025

Nov 03, 2025

Is Arcutis Biotherapeutics Inc. stock undervalued vs historical averages2025 Market Overview & Weekly High Potential Stock Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will earnings trigger a reversal in Arcutis Biotherapeutics Inc.Trade Exit Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Combining price and volume data for Arcutis Biotherapeutics Inc.July 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com

Nov 03, 2025

Nov 03, 2025

How Arcutis Biotherapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Trends & Community Consensus Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Advanced analytics toolkit walkthrough for Arcutis Biotherapeutics Inc.July 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Is Arcutis Biotherapeutics Inc. a candidate for recovery play2025 Market Trends & Accurate Buy Signal Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Arcutis Biotherapeutics Inc. stock deliver consistent dividendsGold Moves & AI Driven Stock Movement Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Will a bounce in Arcutis Biotherapeutics Inc. offer an exitQuarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Is Arcutis Biotherapeutics Inc. stock safe for conservative investorsShort Setup & Fast Gain Stock Trading Tips - newser.com

Nov 02, 2025

Nov 02, 2025

Why hedge funds are buying Arcutis Biotherapeutics Inc. stockJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com

Nov 02, 2025

Nov 02, 2025

Arcutis Biotherapeutics (NASDAQ:ARQT) Raised to Strong-Buy at Wall Street Zen - MarketBeat

Nov 02, 2025

Nov 01, 2025

Has Arcutis Biotherapeutics Inc. found a price floorJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com

Nov 01, 2025

Nov 01, 2025

Is Arcutis Biotherapeutics Inc. stock dividend yield sustainableIPO Watch & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 01, 2025

Nov 01, 2025

How Arcutis Biotherapeutics Inc. stock reacts to global recession fearsTrend Reversal & Weekly Setup with High ROI Potential - newser.com

Nov 01, 2025

Nov 01, 2025

HC Wainwright Has Positive Forecast for ARQT FY2025 Earnings - MarketBeat

Nov 01, 2025

Nov 01, 2025

Arcutis Biotherapeutics (NASDAQ:ARQT) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat

Nov 01, 2025

Oct 31, 2025

Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 40,000 Shares - MarketBeat

Oct 31, 2025

Oct 31, 2025

Why Arcutis Biotherapeutics (ARQT) Is Up 23.9% After Expanding ZORYVE to Pediatric Atopic Dermatitis - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

HC Wainwright Has Positive Outlook for ARQT Q4 Earnings - MarketBeat

Oct 31, 2025

Oct 31, 2025

Arcutis Biotherapeutics, Inc. (ARQT) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

Results: Arcutis Biotherapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st

Oct 31, 2025

Oct 31, 2025

What the charts say about Arcutis Biotherapeutics Inc. todayChart Signals & Reliable Price Action Trade Plans - newser.com

Oct 31, 2025